Matthew R Lammi Selected Research

Matthew R Lammi Research Topics

Disease

6	Pulmonary Hypertension 01/2022 - 01/2012
5	Chronic Obstructive Pulmonary Disease (COPD) 04/2021 - 10/2015
5	Inflammation (Inflammations) 04/2021 - 07/2015
3	Pulmonary Arterial Hypertension 01/2021 - 03/2016
3	Respiratory Hypersensitivity 01/2016 - 02/2015
3	Eosinophilia 12/2015 - 02/2015
3	Asthma (Bronchial Asthma) 12/2015 - 02/2015
2	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 03/2016
1	Sarcoidosis (Schaumann Disease) 01/2022
1	Familial Primary Pulmonary Hypertension 01/2021
1	Overweight 10/2020
1	Lung Diseases (Lung Disease) 10/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Stroke (Strokes) 01/2020
1	Hypoxia (Hypoxemia) 04/2018
1	Dyspnea (Shortness of Breath) 10/2015
1	Shock 10/2015
1	Critical Illness (Critically Ill) 10/2015
1	Neoplasms (Cancer) 07/2015
1	Glioblastoma (Glioblastoma Multiforme) 02/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2015
1	Disease Progression 11/2014
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 11/2014
1	Obstructive Sleep Apnea 01/2014
1	Heart Failure 01/2012
1	Emphysema 01/2012

Drug/Important Bio-Agent (IBA)

3	AllergensIBA 01/2016 - 02/2015
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 04/2021 - 01/2016
2	Iloprost (Ventavis)FDA Link 04/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2015
2	Oxygen (Dioxygen)IBA 12/2019 - 04/2018
2	olaparibIBA 12/2015 - 07/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2015 - 07/2015
2	OvalbuminIBA 07/2015 - 02/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 01/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	insulin receptor-related receptor (IRR)IBA 10/2020
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Metoprolol (Toprol-XL)FDA LinkGeneric 12/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Phosphodiesterase 5 InhibitorsIBA 03/2016
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2016
1	Endothelin Receptor AntagonistsIBA 03/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2016
1	Pancreatic Elastase (Elastase)IBA 01/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2016
1	ProstaglandinsIBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2015
1	Crystalloid SolutionsIBA 10/2015
1	AlbuminsIBA 10/2015
1	8- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA 02/2015
1	CytokinesIBA 02/2015
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 02/2015
1	Immunoglobulin E (IgE)IBA 02/2015
1	DNA-Activated Protein KinaseIBA 02/2015
1	DNA (Deoxyribonucleic Acid)IBA 02/2015
1	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 02/2015
1	Sildenafil Citrate (Viagra)FDA Link 01/2012

Therapy/Procedure

4	Therapeutics 01/2022 - 10/2015
1	Critical Care (Surgical Intensive Care) 10/2020
1	Catheters 10/2015
1	Transplantation 11/2014
1	Continuous Positive Airway Pressure 01/2014
1	Stents 01/2012